Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced ManufacturingCOLUMBIA, S.C., April 23, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose), the nation’s leading contract development and manufacturing organization (CDMO) specializing in sterile Blow-Fill-Seal (BFS) production, welcomed 45 international business students from ESCP Business School April 22 as part of an academic exchange that highlighted global leadership and innovation in pharmaceutical manufacturing.
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution- Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF
Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen PositionCOLUMBIA, S.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation is investing more than $17 million to further its in-house cGMP laboratory capabilities by expanding its analytical chemistry and microbiology laboratories.
